First Bank & Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $359K | Buy |
717
+3
| +0.4% | +$1.44K | 0.05% | 200 |
|
|
2026
Q1 | $351K | Sell |
714
-57
| -7% | -$30.9K | 0.06% | 184 |
|
|
2025
Q4 | $447K | Sell |
771
-8
| -1% | -$4.52K | 0.07% | 168 |
|
|
2025
Q3 | $378K | Sell |
779
-90
| -10% | -$41.9K | 0.06% | 176 |
|
|
2025
Q2 | $352K | Sell |
869
-333
| -28% | -$139K | 0.06% | 172 |
|
|
2025
Q1 | $598K | Sell |
1,202
-1,184
| -50% | -$641K | 0.12% | 117 |
|
|
2024
Q4 | $1.24M | Sell |
2,386
-852
| -26% | -$468K | 0.24% | 84 |
|
|
2024
Q3 | $2M | Sell |
3,238
-84
| -3% | -$49.7K | 0.38% | 63 |
|
|
2024
Q2 | $1.84M | Sell |
3,322
-21
| -0.6% | -$12K | 0.37% | 60 |
|
|
2024
Q1 | $1.94M | Sell |
3,343
-266
| -7% | -$149K | 0.4% | 60 |
|
|
2023
Q4 | $1.92M | Sell |
3,609
-8
| -0.2% | -$3.87K | 0.46% | 50 |
|
|
2023
Q3 | $1.83M | Sell |
3,617
-194
| -5% | -$103K | 0.48% | 52 |
|
|
2023
Q2 | $1.99M | Sell |
3,811
-212
| -5% | -$114K | 0.5% | 49 |
|
|
2023
Q1 | $2.32M | Sell |
4,023
-134
| -3% | -$75.5K | 0.61% | 31 |
|
|
2022
Q4 | $2.29M | Buy |
4,157
+447
| +12% | +$237K | 0.64% | 34 |
|
|
2022
Q3 | $1.88M | Buy |
3,710
+208
| +6% | +$116K | 0.69% | 36 |
|
|
2022
Q2 | $1.9M | Buy |
3,502
+600
| +21% | +$330K | 0.62% | 38 |
|
|
2022
Q1 | $1.71M | Buy |
2,902
+207
| +8% | +$119K | 0.53% | 45 |
|
|
2021
Q4 | $1.8M | Buy |
2,695
+167
| +7% | +$104K | 0.76% | 34 |
|
|
2021
Q3 | $1.45M | Buy |
2,528
+15
| +0.6% | +$8.23K | 0.66% | 45 |
|
|
2021
Q2 | $1.27M | Sell |
2,513
-396
| -14% | -$187K | 0.61% | 48 |
|
|
2021
Q1 | $1.33M | Buy |
2,909
+357
| +14% | +$170K | 0.67% | 40 |
|
|
2020
Q4 | $1.19M | Sell |
2,552
-866
| -25% | -$406K | 0.75% | 38 |
|
|
2020
Q3 | $1.51M | Buy |
3,418
+168
| +5% | +$69.4K | 1% | 31 |
|
|
2020
Q2 | $1.18M | Sell |
3,250
-330
| -9% | -$111K | 0.89% | 38 |
|
|
2020
Q1 | $1.01M | Buy |
3,580
+49
| +1% | +$15.5K | 0.91% | 32 |
|
|
2019
Q4 | $1.15M | Sell |
3,531
-3
| -0.1% | -$910 | 0.84% | 35 |
|
|
2019
Q3 | $1.03M | Buy |
3,534
+137
| +4% | +$39.2K | 0.78% | 40 |
|
|
2019
Q2 | $998K | Sell |
3,397
-38
| -1% | -$10.5K | 0.8% | 41 |
|
|
2019
Q1 | $940K | Sell |
3,435
-43
| -1% | -$10.7K | 0.73% | 48 |
|
|
2018
Q4 | $778K | Buy |
3,478
+30
| +0.9% | +$7.04K | 0.66% | 51 |
|
|
2018
Q3 | $824K | Buy |
3,448
+39
| +1% | +$8.97K | 0.62% | 55 |
|
|
2018
Q2 | $706K | Buy |
3,409
+286
| +9% | +$60.7K | 0.54% | 65 |
|
|
2018
Q1 | $645K | Buy |
3,123
+138
| +5% | +$29K | 0.52% | 61 |
|
|
2017
Q4 | $567K | Buy |
2,985
+19
| +0.6% | +$3.64K | 0.45% | 66 |
|
|
2017
Q3 | $561K | Buy |
2,966
+51
| +2% | +$9.24K | 0.46% | 64 |
|
|
2017
Q2 | $509K | Buy |
2,915
+715
| +33% | +$120K | 0.43% | 69 |
|
|
2017
Q1 | $338K | Buy |
+2,200
| New | +$336K | 0.29% | 92 |
|
Other funds holding TMO
LT
ATO
CF
SP
DLA
First Bank & Trust's TMO Position: Q2 2026 in Review
First Bank & Trust increased its Thermo Fisher Scientific (TMO) stake by 0.42% in Q2 2026, buying an estimated $1.44K and bringing the position to 717 shares worth $359K. The position accounts for 0.05% of the portfolio, ranked #200.
First Bank & Trust first reported a position in TMO in Q1 2017 and has held it in 38 quarters since. The position peaked at $2.32M in Q1 2023. 647 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- First Bank & Trust held 717 shares of Thermo Fisher Scientific worth $359K as of Q2 2026.
- First Bank & Trust bought 3 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.44K.
- Thermo Fisher Scientific made up 0.05% of First Bank & Trust's portfolio in Q2 2026, its #200 holding.
- First Bank & Trust first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 38 quarters since.
- First Bank & Trust's Thermo Fisher Scientific position peaked at $2.32M in Q1 2023.
- 647 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.